Phibro Animal Health (PAHC) rallied close to 7% after JPMorgan upgraded the stock and upped its price target. George Tsilis dives into the earnings and analyzes the financial health of the company. He also talks about Phibro's recent $350 million acquisition of Zoetis to explain why it adds to bullish momentum.